AAAAAA
Results:
1-13
|
Results: 13
Authors:
Zhang, B
Shiomi, M
Tanaka, H
Mei, J
Fan, P
Tsujita, Y
Horikoshi, H
Saku, K
Citation: B. Zhang et al., Effects of high-dose troglitazone on insulin sensitivity and beta-cell function in watanabe heritable hyperlipidemic rabbits, EUR J DRUG, 26(3), 2001, pp. 185-192
Authors:
Horikoshi, H
Kinomoto, M
Sasao, F
Mukai, T
Luftig, RB
Ikuta, K
Citation: H. Horikoshi et al., Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules, VIRUS RES, 73(1), 2001, pp. 1-16
Authors:
Ikuta, K
Suzuki, S
Horikoshi, H
Mukai, T
Luftig, RB
Citation: K. Ikuta et al., Positive and negative aspects of the human immunodeficiency virus protease: Development of inhibitors versus its role in AIDS pathogenesis, MICRO M B R, 64(4), 2000, pp. 725
Authors:
Shimizu, K
Shiratori, K
Hayashi, N
Fujiwara, T
Horikoshi, H
Citation: K. Shimizu et al., Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus, PANCREAS, 21(4), 2000, pp. 421-426
Authors:
Fujiwara, T
Horikoshi, H
Citation: T. Fujiwara et H. Horikoshi, Troglitazone and related compounds - Therapeutic potential beyond diabetes, LIFE SCI, 67(20), 2000, pp. 2405-2416
Authors:
Oguchi, M
Wada, K
Honma, H
Tanaka, A
Kaneko, T
Sakakibara, S
Ohsumi, J
Serizawa, N
Fujiwara, T
Horikoshi, H
Fujita, T
Citation: M. Oguchi et al., Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2,4-diones, J MED CHEM, 43(16), 2000, pp. 3052-3066
Authors:
Yokoyama, T
Yoshida, Y
Inoue, T
Horikoshi, H
Citation: T. Yokoyama et al., Inhibition of galactose-induced cataractogenesis by troglitazone, a new antidiabetic drug with an antioxidant property, in rat lens culture, J OCUL PH T, 15(1), 1999, pp. 73-83
Authors:
Kon, Y
Horikoshi, H
Endoh, D
Citation: Y. Kon et al., Metaphase-specific cell death in meiotic spermatocytes in mice, CELL TIS RE, 296(2), 1999, pp. 359-369
Authors:
Mori, Y
Murakawa, Y
Okada, K
Horikoshi, H
Yokoyama, J
Tajima, N
Ikeda, Y
Citation: Y. Mori et al., Effect of troglitazone on body fat distribution in type 2 diabetic patients, DIABET CARE, 22(6), 1999, pp. 908-912
Authors:
Horikoshi, H
Miyano, H
Takayasu, T
Nitta, M
Citation: H. Horikoshi et al., Umpolung of tropone: Preparation of 2-aroyl- and 2-acyltropones, SYN COMMUN, 29(24), 1999, pp. 4367-4373
Authors:
Ogawa, J
Takahashi, S
Fujiwara, T
Fukushige, J
Hosokawa, T
Izumi, T
Kurakata, S
Horikoshi, H
Citation: J. Ogawa et al., Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice, LIFE SCI, 65(12), 1999, pp. 1287-1296
Authors:
Shiomi, M
Ito, T
Tsukada, T
Tsujita, Y
Horikoshi, H
Citation: M. Shiomi et al., Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows synergistic effect on atherosclerosis of WHHL rabbits, ATHEROSCLER, 142(2), 1999, pp. 345-353
Authors:
Ishibashi, K
Nakajima, K
Sugioka, Y
Sugiyama, M
Hamada, T
Horikoshi, H
Nishi, T
Citation: K. Ishibashi et al., Synthesis of 2-phenylbenzofuran derivatives as testosterone 5 alpha-reductase Inhibitor, CHEM PHARM, 47(2), 1999, pp. 226-240
Risultati:
1-13
|